Bilirubin: A Promising Therapy for Parkinson's Disease.
Following the increase in life expectancy, the prevalence of Parkinson's disease (PD) as the most common movement disorder is expected to rise. Despite the incredibly huge efforts in research to find the definitive biomarker, to date, the diagnosis of PD still relies mainly upon clinical symptoms. A wide range of treatments is available for PD, mainly alleviating the clinical symptoms. However, none of these current therapies can stop or even slow down the disease evolution. Hence, disease-modifying treatment is still a paramount unmet medical need. On the other side, bilirubin and its enzymatic machinery and precursors have offered potential benefits by targeting multiple mechanisms in chronic diseases, including PD. Nevertheless, only limited discussions are available in the context of neurological conditions, particularly in PD. Therefore, in this review, we profoundly discuss this topic to understand bilirubin's therapeutical potential in PD.
['Jayanti|Sri|S|', 'Moretti|Rita|R|0000-0002-9731-2697', 'Tiribelli|Claudio|C|0000-0001-6596-7595', 'Gazzin|Silvia|S|0000-0001-9403-3564']
D001663:Bilirubin D006801:Humans D010300:Parkinson Disease
bilirubin Parkinson’s disease disease-modifying therapy yellow players